Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Trelehan Labs ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.2% 1.2%   Bankruptcy risk   20.8% 18.7% 16.3% 22.3% 13.7% 17.3% 15.9% 15.8%   Credit score (0-100)   6 8 11 3 15 8 12 12   Credit rating   B B BB B BB BB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   6 6 6 12 400 190 190 190   Gross profit   1.4 1.9 2.2 -15.3 368 149 0.0 0.0   EBITDA   1.4 1.9 2.2 -15.3 123 -30.4 0.0 0.0   EBIT   1.4 1.9 2.2 -15.3 123 -30.4 0.0 0.0   Pre-tax profit (PTP)   1.4 1.9 2.2 -15.3 123.3 -30.4 0.0 0.0   Net earnings   1.4 1.9 2.2 -15.3 96.2 -30.4 0.0 0.0   Pre-tax profit without non-rec. items   1.4 1.9 2.2 -15.3 123 -30.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -5.8 -3.9 -1.7 19.5 116 10.2 -29.8 -29.8   Interest-bearing liabilities   6.6 5.5 2.5 0.0 0.7 0.0 29.8 29.8   Balance sheet total (assets)   0.9 2.0 1.2 18.8 190 36.7 0.0 0.0   Net Debt   5.7 3.5 2.0 -18.8 -96.8 -5.1 29.8 29.8     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   6 6 6 12 400 190 190 190   Net sales growth   0.0% 0.0% 0.0% 96.6% 3,289.2% -52.4% 0.0% 0.0%   Gross profit   1.4 1.9 2.2 -15.3 368 149 0.0 0.0   Gross profit growth   -62.5% 32.3% 16.6% 0.0% 0.0% -59.3% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1 2 1 19 190 37 0 0   Balance sheet change%   -69.7% 119.2% -39.9% 1,488.3% 913.0% -80.7% -100.0% 0.0%   Added value   1.4 1.9 2.2 -15.3 123.3 -30.4 0.0 0.0   Added value %   24.0% 31.7% 36.9% -130.0% 30.8% -16.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 1.0 2.0 -1.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 -1.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   24.0% 31.7% 36.9% -130.0% 30.8% -16.0% 0.0% 0.0%   EBIT %   24.0% 31.7% 36.9% -130.0% 30.8% -16.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 33.5% -20.3% 0.0% 0.0%   Net Earnings %   24.0% 31.7% 36.9% -130.0% 24.1% -16.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   24.0% 31.7% 36.9% -130.0% 24.1% -16.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   24.0% 31.7% 36.9% -130.0% 30.8% -16.0% 0.0% 0.0%   ROA %   17.0% 30.2% 50.6% -141.7% 118.0% -26.8% 0.0% 0.0%   ROI %   17.3% 31.4% 55.4% -139.7% 181.5% -48.1% 0.0% 0.0%   ROE %   74.5% 132.8% 140.8% -148.6% 142.4% -48.3% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   76.8% 80.9% 68.2% 96.6% 60.8% 27.8% -100.0% -100.0%   Relative indebtedness %   111.8% 97.9% 47.9% -5.9% 18.6% 13.9% 15.7% 15.7%   Relative net indebtedness %   96.9% 65.2% 39.0% -165.0% -5.7% 11.2% 15.7% 15.7%   Net int. bear. debt to EBITDA, %   397.7% 185.9% 88.7% 122.4% -78.5% 16.9% 0.0% 0.0%   Gearing %   -113.8% -140.7% -147.6% 0.0% 0.6% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   4.3 5.2 3.1 -27.1 2.6 1.4 0.0 0.0   Current Ratio   4.3 5.2 3.1 -27.1 2.6 1.4 0.0 0.0   Cash and cash equivalent   0.9 2.0 0.5 18.8 97.5 5.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 76.4 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   15.0% 32.8% 19.7% 159.2% 47.6% 19.3% 0.0% 0.0%   Net working capital   0.7 1.6 0.8 19.5 115.6 10.2 -14.9 -14.9   Net working capital %   11.5% 26.5% 13.4% 165.0% 28.9% 5.4% -7.8% -7.8%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0